|
Real-time Estimate
Cboe BZX
12:25:26 2026-10-19 EDT
|
5-day change | 1st Jan Change | ||
| 0.9500 USD | -2.89% |
|
-0.80% | -43.32% |
| 09-30 | EARNINGS: Generation Essentials interim profit jumps to USD28 million | AN |
| 08-07 | Lineage Cell Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 |
Chart: Technical Analysis
NYSEUSD
| Markets | Quality | ||
|---|---|---|---|
NYSE
| LCTX | Delayed | |
TEL AVIV STOCK EXCHANGE
| LCTX | Delayed | |
CBOE
| LCTX | Real-time | |
Tradegate
| BT3 | Real-time | |
Deutsche Boerse AG
| BT3 | Delayed | |
Börse Stuttgart
| BT3 | Delayed | |
Boerse Muenchen
| BT3 | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 1.09 | 1.14 | 1.35 |
| Spread/Res. | -13.17% | -16.97% | -29.89% |
| Spread/Supp. | +4.68% | +4.68% | +1.74% |
| Support | 0.9042 | 0.9042 | 0.9303 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- LCTX Stock
- Charts Lineage Cell Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions

















